iTernity, a provider of enterprise-grade software-defined storage (SDS) archiving infrastructure merges with biomedion, a German specialist in GxP-compliant data management software for the pharmaceutical industry. Through the combination, iTernity adds expertise in the highly regulated pharmaceutical vertical, while maintaining its broader focus of being a sector agnostic data management solution provider.
Founded in 2004 and headquartered in Freiburg, Germany, iTernity develops software-defined storage for archiving and backups that ensure long-term data protection and regulatory compliance. Its flagship products, iCAS and iCAS FS, are deployed by over 1400 international customers across healthcare, automotive, public sector, pharma, and industrial verticals. The company’s partner-led sales model and scalable software architecture have contributed to strong growth and customer retention. The management team from iTernity – Armin Weißer and Tobias Neerfeld – remains committed and will stay onboard for the company’s next growth chapter.
The merger combines biomedion’s expertise in GxP-compliant data archiving with exclusive focus on the pharmaceutical industry with iTernity’s enterprise-grade SDS infrastructure. biomedion’s flagship platform, Watcher, automates the secure storage of raw laboratory data in highly regulated environments. iTernity’s solutions, including iCAS and ICAS FS, offer scalable, tamper-proof archiving across a wide range of industries. Together, the companies now offer a comprehensive and modern software suite consisting of:
1) ICAS and ICAS FS – horizontal archiving solutions for enterprise-wide compliance and data protection as well as
2) Watcher – a specialized platform focusing on data integrity and archiving in the pharmaceutical industry.
The newly formed group is powered by a team of experienced professionals with deep industry knowledge. Their unified offering strengthens data integrity, supports regulatory compliance, and ensures audit readiness for customers across sectors.
Andreas Hepfner, CEO of biomedion, comments: "We are pleased to collaborate with iTernity in a broader group setting. Their expertise in scalable archiving and data protection complements our strengths in regulated data management. By combining our capabilities, we can offer a more complete platform that meets the increasing demands of compliance, data volume, and operational resilience."
Armin Weißer, CEO of iTernity, adds: "Joining forces with biomedion marks an important step in iTernity’s evolution. We share a strong commitment to data integrity and compliance, and together we can deliver broader, more integrated solutions to our customers. This partnership opens new opportunities for innovation, growth, and long-term value for our clients and partners."
Eike Eul, Director at Main Capital Partners, concludes: "This acquisition embodies a strategic milestone towards our ambition of building a leading European software group within data management and archiving solutions.”
Founded in 2000 and headquartered in Berlin, Germany, biomedion provides GxP-compliant data management software for the life sciences industry. Its core product, Watcher, enables automated, audit-ready archiving of raw data from lab instruments in line with global regulatory standards. The company serves top pharmaceutical and biosimilar firms, CROs, and biotech’s across Europe and North America.
About iTernity
Founded in 2004 and headquartered in Freiburg, Germany, iTernity develops software-defined storagefor archiving and backup solutions that ensure long-term data protection and regulatory compliance. Its core products, iCAS and iCAS FS, enable tamper-proof, scalable storage of critical business data across sectors such as healthcare, the public sector, and industry. The company supports over 1400 customers through a strong partner network.
About Main Capital Partners
Main Capital Partners is a leading software investor managing private equity funds active in the Benelux, DACH, France, the Nordics, and the United States with approximately EUR 6.5 billion in Assets under Management. Main has over 20 years of experience in strengthening software companies and works closely with the management teams in its portfolio as a strategic partner to achieve profitable growth and larger outstanding software groups. As a leading software investor managing private equity funds active in Northwestern Europe and North America, Main has more than 90 employees operating out of its offices in The Hague, Düsseldorf, Stockholm, Antwerp, Paris, and an affiliated office in Boston. Main maintains an active portfolio of over 57 software companies. The underlying portfolio employs over 12,000 employees. Through its Main Social Institute, Main supports students with grants and scholarships to study IT and Computer Science at Technical Universities and Universities of Applied Sciences.
Official Press Release of Main Capital Partners
Nothing contained in this Press Release is intended to project, predict, guarantee, or forecast the future performance of any investment. This Press Release is for information purposes only and is not investment advice or an offer to buy or sell any securities or to invest in any funds or other investment vehicles managed by Main Capital Partners or any other person.